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A renovated telephone factory adds a prime St. Louis
location to commercialize research technology, a place
where students and trainees can engage creatively with
businesspeople and investors in biomedicine. This office
and lab facility at 4240 Duncan Ave., dubbed @4240,
provides space for established and start-up companies.
The Office of the Vice Chancellor for Research and other
university tenants anchor this new $73-million facility,
located in the CORTEX bioscience district just east of
Washington University Medical Center.
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A Bangladeshi
mother holds her
malnourished child.
The dark spot placed
on his head is said to
ward off evil spirits.

Microbes & malnutrition

Problem affecting millions of children may be rooted in underdeveloped gut communities

N

ew findings may help explain why
millions of malnourished children
suffer from stunted growth and fail
to thrive after treatment with nutrient-rich
therapeutic foods.
Studying healthy and malnourished young
children in Bangladesh, a team at the School
of Medicine found that malnutrition has persistent detrimental effects on the vast community of microbes living in the gut. These
“friendly” microbes typically aid in extracting
nutrients and calories from food, and perform
many other vital functions.
The results suggest that the long-term
consequences of childhood malnutrition, such
as stunted growth, cognitive problems and
weakened immune systems, may be rooted in
lingering, underdeveloped gut microbes that
can’t fully harvest energy and calories from
food, said senior author Jeffrey I. Gordon, MD,
director of Washington University’s Center for
Genome Sciences & Systems Biology.
2 Washington University School of Medicine

In healthy children, the researchers identified features associated with normal development of the gut’s community of microbes. In
comparison, they noted that malnourished
children carried communities of gut microbes
that did not mature along a normal trajectory.
These immature bacterial collections could
not be restored to good health with standard
treatments of therapeutic foods.
The research, conducted in collaboration
with colleagues at the International Centre for
Diarrhoeal Disease Research in Dhaka,
Bangladesh, is published online in Nature.

These immature bacterial
collections could not
be restored to good
health with food-based
interventions.

“Although therapeutic food-based interventions have resulted in a significant decline in
deaths from malnutrition, many children never
fully recover,” said first author Sathish
Subramanian, a Washington University MD/
PhD student. “We found that children who
were malnourished had gut microbial communities that were not consistent with their
chronological ages. The severity of a child’s
malnourishment was tied closely with the
degree of immaturity of his or her gut microbial community, and this immaturity could not
be durably repaired with standard treatments.”
The researchers are following up their
research in animal models colonized with
immature gut microbe communities from malnourished children. They are seeking to determine whether giving therapeutic foods for
longer periods of time or administering beneficial mixtures of naturally occurring human gut
microbes can repair this immaturity and
improve health.
Autumn 2014

How gene-lifestyle interactions
affect cardiovascular disease
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Investigators Ingrid
Borecki, PhD, and
D.C. Rao, PhD

CLEM SPALDING

School of Medicine researchers have received an $8 million
grant to investigate the genetic and environmental roots
of cardiovascular disease risk factors. The four-year grant
supports the first large-scale, multiethnic statistical analysis
of risk factors for cardiovascular disease that looks at
lifestyle interactions with genes.
The investigators will use existing data from more than
30 studies, which include detailed genetic data, measures
of cardiovascular risk factors — namely, blood pressure
and cholesterol levels — as well as information on lifestyle,
including smoking, alcohol consumption, physical activity,
socioeconomic status and diet.
To carry out this type of study, large numbers of subjects
are needed to have sufficient power to detect interactions of
genes and lifestyle.
The study represents a massive international collaboration
that brings together data on more than 300,000 subjects from
diverse ethnicities. The multiethnic approach allows a broad
view of interactions and how they play out in populations
with different genetic and cultural histories.
“This study is unprecedented in many ways,” said principal
investigator D.C. Rao, PhD, professor of biostatistics, genetics,
psychiatry and mathematics and director of the Division of
Biostatistics.
“We have compelling preliminary data that highlight the
potential of these investigations,” he said. “We found, for
example, several novel genes associated with high blood pressure that were not previously known until the interactions
with alcohol consumption or education were brought in.”
Considering lifestyle factors in the context of a genetic
analysis offers the possibility of identifying novel genes and
may provide clues to intervention points.

STEVE DOLAN

RABIUL HASAN, INTL CENTRE FOR DIARRHOEAL DISEASE RESEARCH

$8 million grant a first for scale and scope

Uncommon monkey Researchers at The Genome
Institute at Washington University and at Baylor College of Medicine
have decoded the genome of the common marmoset. A look at
its DNA begins to explain the animal’s frequent twin births; most
primate species have single births. Unlike humans, marmosets consistently give birth to twins without any medical issues. Marmoset gene
changes associated with twinning perhaps act as a critical switch
between multiple and single pregnancies. Findings could shed light
on multiple pregnancies in humans.

Earhart named PT program director
Gammon Earhart, PhD, professor of physical therapy, now
is director of the Program in Physical Therapy at the School
of Medicine. She succeeds Susie Deusinger, PhD, who has
retired.
Larry J. Shapiro, MD, executive vice chancellor for medical affairs and dean of the
medical school, announced the appointment.
“Gammon Earhart is an innovative
thinker, a well-respected researcher and a
leader in physical therapy,” Shapiro said.
“She is exceptionally qualified to continue
the legacy of excellence Susie Deusinger built
during her 24 years as director.”
Earhart, also a professor of neurobiology
and of neurology, joined the faculty in 2004. Gammon Earhart, PhD
A 2000 graduate of the Movement Science
PhD Program, she is associate director of that program.
Earhart earned undergraduate and master’s degrees from
Arcadia University in Pennsylvania and did postdoctoral
work at Oregon Health and Science University.
Earhart’s research focuses on nervous system control of
movement and examines how different treatment approaches
may benefit people with Parkinson’s disease.
Under Deusinger’s leadership, the program evolved into
one of the top programs in the country and consistently
ranks among the best, according to U.S. News & World Report.
Outlook 3

pulse
New center aims to use immune
system to fight cancer, diseases

Senior prom Johanna Kaufman, medical student and leader
of the Geriatrics Outreach Group, dances with Don Harper. Harper
was one of about 200 St. Louis-area seniors who attended the annual
prom in the 560 Music Building. The event fosters intergenerational
dialogue, social interaction for seniors and is a learning opportunity
for students. The prom is hosted by student volunteers from the
medical school, the programs in Physical Therapy and Occupational
Therapy and the undergraduate schools.

Cardiothoracic surgery chief named
Ralph J. Damiano Jr., MD, an internationally known cardiac surgeon, has been named chief of the Division of
Cardiothoracic Surgery at the School of Medicine.
The new appointment is one of several taking effect in the
cardiothoracic surgery division. With
his appointment, Damiano becomes
the Evarts Ambrose Graham Professor
of Surgery. He succeeds G. Alexander
Patterson, MD, who has served as chief of
cardiothoracic surgery since 2005.
Patterson, who becomes the Joseph
C. Bancroft Professor of Cardiothoracic
Surgery, has stepped down as division
chief to devote more time to editing The
Annals of Thoracic Surgery, the journal
Ralph J. Damiano Jr., MD
of The Society of Thoracic Surgeons. He
is editor-elect of the journal and will become editor-in-chief
early next year.
Marc Moon, MD, succeeds Damiano as chief of the
Section of Cardiac Surgery.
“We have tremendous depth and breadth in the Division
of Cardiothoracic Surgery,” said Timothy J. Eberlein, MD, the
Bixby Professor and chairman of the Department of Surgery,
in announcing the new appointments. “Our cardiothoracic
surgeons are national and international leaders in developing
and refining innovative surgical procedures for the heart and
for pulmonary diseases. We are grateful to Alec Patterson for
his many years of dedicated service in leading the division to
Enjoy interactive elements and added content
additional prominence and look forward to Ralph Damiano
continuing the long tradition of leadership in the field.”
4 Washington University School of Medicine

A new center will help scientists use the power of the
immune system to fight infections and cancers.
The Center for Human Immunology and Immunotherapy
Programs (CHiiPs) is part of BioMed21, the university’s initiative to accelerate basic science discoveries into improved
diagnosis and treatment for patients. The center is housed in
the BJC Institute of Health at Washington University.
Scientists also are developing ways to restrain the
immune system when it mistakenly attacks healthy tissue,
leading to autoimmune disorders.
“Several very important basic discoveries in these areas
have been made by Washington University faculty, but it has
been challenging to move those discoveries into the clinic,”
said CHiiPs director Robert D. Schreiber, PhD, the Alumni
Professor of Pathology and Immunology.
Pioneering researchers at the medical school have shown
that the immune system can recognize cancers and regulate
their growth. The scientists also have identified ways to
manipulate the immune system’s ability to destroy cancer
cells. The school has been a leader in developing vaccines for
emergent diseases such as West Nile virus and in identifying
cells and molecules involved in autoimmune conditions.
A center laboratory will monitor changes in the immune
system during clinical trials of new immunotherapies.
“Until now, faculty performing immunological clinical
trials or studying unique immunologic clinical syndromes
had to set up these tests in their own labs, which is a lot of
work and doesn’t always produce standardized results,”
Schreiber said.
The center’s leaders are recruiting faculty interested in
applying immunological discoveries to clinical problems.

ROBERT BOSTON

RAY MARKLIN
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The center’s new time-of-flight mass cytometer simultaneously detects more
than 50 different structures either on the cell surface or inside the cell, providing important clues to the identity of the cells and the functions they perform.
From left, center leaders Olga Malkova, PhD; Stephen Oh, MD, PhD; Michael
Diamond, MD, PhD; Robert Schreiber, PhD; and Wayne Yokoyama, MD.
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Before the
Cardinals, there
were colleges

PHIL SKROSKA • ARCHIVES AND RARE BOOKS

St. Louis Medical College in the 1870s

Missouri Medical College and St. Louis Medical
College. These two colleges later would merge to
become Washington University School of Medicine.
To see maps, photos and learn more about these
historical roots, visit bit.ly/1pu2xPx.

The first phase of Ballpark Village, a mixed-use
entertainment and retail district next door to Busch
Stadium in St. Louis, opened for this year’s baseball
season. But, in the 1870s, this area was the epicenter
of medical education in St. Louis — home to the two
oldest medical schools west of the Mississippi:

RADIOLOGY RESEARCH

S

cientists have advanced a brainscanning technology that tracks what
the brain is doing by shining dozens
of tiny LED lights on the head. This new generation of neuroimaging compares favorably,
while avoiding the radiation exposure and
bulky magnets other approaches require,
according to School of Medicine research.
The new optical approach to brain scanning is ideally suited for children and for
patients with electronic implants, such as
pacemakers, cochlear implants and deep brain
stimulators (used to treat Parkinson’s disease).
The magnetic fields in magnetic resonance
imaging (MRI) often disrupt either the function or safety of implanted electrical devices,
whereas there is no interference with the optical technique.
The new technology is called diffuse optical tomography (DOT). While researchers have
been developing it for more than 10 years,
the method had been limited to small regions
of the brain. The new DOT instrument covers
two-thirds of the head and for the first time
can image brain processes taking place in
outlook.wustl.edu

multiple regions and brain networks such as
those involved in language processing and
self-reflection (daydreaming).
“When the neuronal activity of a region in
the brain increases, highly oxygenated blood
flows to the parts of the brain doing more
work, and we can detect that,” said senior
author Joseph Culver, PhD, associate professor
of radiology. “It’s roughly akin to spotting the
rush of blood to someone’s cheeks when
they blush.”
The technique works by detecting light
transmitted through the head and capturing
the dynamic changes in the colors of the
brain tissue.
Although DOT technology now is used in
research settings, it has the potential to be
helpful in many medical scenarios as a surrogate for functional MRI, the most commonly
used imaging method for mapping human
brain function. Functional MRI also tracks
activity in the brain via changes in blood flow.
Another common method for mapping
brain function is positron emission tomography (PET), which involves radiation expo-

TIM PARKER

The next generation of brain scanning

sure. Because DOT technology does not use
radiation, multiple scans performed over time
could be used to monitor patients treated for
brain injuries, developmental disorders such
as autism, neurodegenerative disorders such
as Parkinson’s, and other diseases.
Unlike fMRI and PET, DOT technology is
designed to be portable, so it could be used at
a patient’s bedside or in the operating room.
While DOT doesn’t let scientists peer very
deeply into the brain, researchers can get reliable data to a depth of about one centimeter
of tissue. That centimeter contains some of the
brain’s most important and interesting areas
with many higher brain functions represented.
Outlook 5
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Could a single medication fight
multiple infectious agents?
$32 million NIH grant will fund project

Winning graduate students Hirak Biswas, Whitney Grither and Anurag Agarwal.

Breast cancer startup challenge
The resources required to get discoveries from bench to bedside can be astounding. Many promising innovations never
reach their potential.
To reverse this trend, The Avon Foundation for Women,
the National Cancer Institute (NCI) and the Center for
Advancing Innovation created the Breast Cancer Startup
Challenge. The initiative was aimed at bringing 10 promising
breast cancer discoveries out of the lab and closer to market.
Some 200 teams of graduate students worldwide competed. Graduate students Hirak Biswas and Anurag Agarwal
in the Division of Biology and Biomedical Sciences and
Whitney Grither in the Medical Scientist Training Program
won for their proposal to advance a therapeutic breast cancer
vaccine developed by NCI researchers and patented in 2011.
The team also included Gurudatta Begur Nadiger, an executive MBA student at Northwestern University, and Erik Nyre,
a law student at the University of Minnesota.
The vaccine showed promise in preclinical mouse trials,
but further research and development is needed. This
would be the focus of the startup company. The team
must negotiate an exclusive licensing agreement with the
NCI’s technology transfer office and raise seed funding.
School of Medicine faculty members mentored the students.

Neuro thriller

Neurosurgeon Eric
Leuthardt’s research often has been described
as science fiction brought to life. An associate
professor of neurosurgery and of biomedical engineering, Leuthardt, MD, is working to
develop brain implants known as neuroprosthetics that detect brain signals and relay them
to a computer. He hopes to use the technology
to restore movement, speech and other functions in people suffering from stroke.
Experiences in the lab and the operating room
inspired him to write a futuristic thriller. His
first novel, “RedDevil 4,” envisions a world where brain implants
permeate every level of personal and social interaction as cellEnjoy
elements and added content
phones
do interactive
today.

6 Washington University School of Medicine

School of Medicine researchers are leading a multi-institutional campaign to harness a newly recognized cellular
defense against infection.
The project could lead to drugs with unprecedented versatility in fighting different infections. A $32 million grant
from the National Institutes of Health (NIH) is funding the
collaborative, which also includes Massachusetts General
Hospital, the Broad Institute and the University of Texas
Southwestern Medical Center.
The grant creates a four-site Center for Excellence
in Translational Research (CETR), which is a National
Institutes of Allergy and Infectious
Diseases program.
“If we’re successful, we
may develop drugs that
allow us to treat bacteria, viruses, fungi and
parasites with a single
medication,” said
principal investigator
Herbert W. Virgin IV,
MD, PhD, head of the
university’s Department
of Pathology and
Immunology. “We now
have drugs that can take on
viruses or bacteria but nothUsing a newly recognized
ing that can fight several
cellular defense system
types of infectious agents at
to fight infection
the same time.”
Virgin and his colleagues
are investigating a newly recognized connection between
a cellular waste disposal system called autophagy and the
body’s ability to fend off infections.
Scientists already knew that autophagy proteins clean out
cellular debris. But researchers recently have started to link
the proteins to infection control, suggesting that the disposal
system may not only take out the trash but also help identify
unwanted cellular houseguests — such as bacteria, viruses,
fungi or parasites — and destroy them.
Other proteins involved in autophagy may fight infection
in different ways, indicating that this pathway is a versatile
tool used by the body to fight a range of infections.
The researchers will identify proteins involved in autophagy, explore the roles the proteins play in waste disposal and
immunity, and attempt to develop drugs that engage the
autophagy process in fighting infections.
Autumn 2014
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‘Printing’ a new
arm for Sydney

PHOTOS BY ROBERT BOSTON
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hirteen-year-old Sydney Kendall had
one request for the students building
her robotic prosthetic arm: Make it pink.
Kendall Gretsch, Henry Lather and Kranti
Peddada, 2014 seniors studying biomedical
engineering in the School of Engineering &
Applied Science, accomplished that and more,
with guidance from School of Medicine faculty.
Using a 3-D printer,
they created a robotic prosthetic arm out of brightpink plastic. Total cost:
$200, a fraction of the price
of standard prosthetics,
which start at $6,000.
“Currently, prosthetics
are very expensive, and
because kids keep growing,
it is too costly for them to
have the latest technology,”
said Sydney’s mother,
Beth Kendall.
While 3-D printers can
cost about $2,500, they are
capable of producing artificial limbs at a
relatively low individual cost.
Sydney lost her arm in a boating accident
at age 6. She learned to write with her left
hand, but found most tasks difficult to accomplish with her prosthetic arm. Sydney said
her new arm is easy to manipulate. By moving
her shoulder, she can direct the arm to
throw a ball, move a computer mouse and
perform other tasks.
The students developed the robotic hand
as part of an engineering design course with
Joseph Klaesner, PhD, associate professor of
physical therapy at the medical school. Charles
A. Goldfarb, MD, and Lindley Wall, MD, orthopedic hand surgeons and associate professors
of orthopaedic surgery, served as mentors.
“They brought their engineering expertise, and we shared our practical experience
with prosthetics and the needs of children,”
Goldfarb said.
Outlook 7

Paving the
road to

E

RESIDEN

ver y summer, at teaching hospitals across the country, newly

PHOTOS BY
ROBERT BOSTON

Theory put into practice:
facilitators L. Michael
Brunt, MD, Julie
Woodhouse and
Thomas M. De Fer, MD

8 Washington University School of Medicine

minted MDs formally begin introducing themselves as “doctors.”
Despite years of preparation, it’s a steep learning curve —
going from student, observer and helper, to being an on-call resident,
writing orders and managing high-acuity patients through long nights.
Given significant changes in U.S. residency training — and
reduction of hospital duty hours — residents are facing new
challenges. Nationally, medical schools are thinking beyond the
four-year experience and trying to offer more seamless transitions
to residency. To help graduating students hit the ground running,
School of Medicine faculty created “Capstone,” a four-week,
robust hands-on course.
Capstone course
“We are convinced it
makes an impact at the outset
builds confidence
of internship,” said course cofounder L. Michael Brunt, MD,
in critical decisionprofessor of surgery. “This is an
making, hones
important first step leading to
more specialized curriculum
hands-on skills of
development that will better
tomorrow’s physicians
prepare our students for
residency training.”
Through morning didactic sessions and
afternoon procedure workshops, students cover
many of the situations they soon will encounter
in real life. Theoretical lectures are replaced
with practical application, taking students’ accumulated knowledge
— from first-year anatomy to third-year clerkships — and putting
it all together.
Here, they begin thinking like independent physicians, focusing
on day-to-day tasks and in-the-moment decision-making, such as
juggling multiple patients or choosing the right medication dosages.
The students refine technical skills — suturing, placing a central
intravenous line, or inserting a chest tube — procedures that, in
some cases, they’ve only observed. Specialty-specific breakout
sessions further reinforce essential clinical competencies.
Autumn 2014
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Students practice inserting
chest tubes into racks of
ribs. This procedure is
used in patients with
a pneumothorax
(collapsed lung).
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A P S T O N E , created three years ago as a
two-week elective by Brunt and Thomas M.
De Fer, MD, professor of medicine, continues to
evolve based on student and faculty feedback.
“Capstone provides a ‘just-in-time’ learning
experience for medical students who are a few
months away from being an intern,” DeFer said.
“That’s always been anxiety-provoking, but,
until courses like this, it was just something
that they had to work through as best as
they could and hopefully not make too many
mistakes along the way.
“Our students do get a lot of these
educational elements earlier in the curriculum,
but it’s always a challenge to retain it all.
This course provides practical information in
one fell swoop at a time when they need it
the most and are most receptive.”

As par t of the core curriculum in
2014 –15, the four-week session will run twice,
with each of the many procedural workshops
offered multiple times, to accommodate the
entire medical class. Hundreds of faculty and
house staff members from many disciplines
are involved in the program. Coordination is
a year-round logistical challenge headed by
Julie Woodhouse, assistant director of the
Howard & Joyce Wood Simulation Center.
“Capstone is one of our success stories.
The whole school comes together and
contributes to it,” said Michael M. Awad, MD,
PhD, associate dean for medical student
education.

outlook.wustl.edu
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A P S T O N E topics address the curricula
of modern medicine — patient safety,
emergency management, end-of-life care,
informed consent, ethics, working in a team,
communication, and sign-outs and handoffs,
among many others. In addition, the class gives
students tips to manage their personal wellness
(dealing with stress, time management and
sleep deprivation).
Rated particularly high among students
are the “mock page” sessions. Nurses call in a
scenario, i.e., “the patient had surgery yesterday
and is now running a fever,” and students are
forced to think through the next steps.

Capstone students recently completed
pre- and post-course questionnaires assessing
their ability to handle clinical problems,
procedures and patient-care tasks. In all
categories, students rated their abilities
markedly higher post-course.
“The thing many of us felt the most
apprehension about was getting that call in
the middle of the night about a patient who
wasn’t doing well,” said Linda Jin, MD, now a
first-year surgical resident at Barnes-Jewish
Hospital. “Even through fourth year, most of
our education is focused on understanding
pathophysiology and knowing what is in
the literature.
“Capstone helped us synthesize our
knowledge so we can apply it in a practical
way. It was also so useful to have a forum to
practice saying things like ‘I’d like a chest X-ray,
CBC and BMP now’ in a safe environment.
One week into my intern year, I said those
exact things. I’m glad I had a chance to do a
practice run.”
— Deb Parker

12 Washington University School of Medicine
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Ability to see glowing cancer cells opens doors
to precision treatments B Y J I M G O O D W I N

n c e rV I S I O N

C A N C E R C E L L S A R E N O T O R I O U S LY
difficult to see, even under high magnification.
Until now, it’s been nearly impossible for operating
surgeons — using only static MRIs and X-rays as a
guide — to tell where the tumor ends and healthy
tissue begins.
After hearing a group of doctors discuss
this frustration in 2009, Samuel Achilefu, PhD,
a professor of radiology at the School of Medicine,
had an idea: Could night-vision goggles used by
the military also work in the war against cancer?
Achilefu’s mission was to design wearable
technology for surgeons, helping them
distinguish cancer cells from healthy cells in real time
— perhaps reducing the need for additional surgeries
and subsequent stress on patients.

The goggles evolved from an effective
but clunky prototype (left), into a
more streamlined version for testing
in the O.R. (middle). The version
currently in development (right)
provides a clear view of the surgical
field and the ability to visualize
cancer cells (highlighted here in
orange). The goggles are modeled
by Suman Mondal, a PhD candidate
in biomedical engineering, who is
coordinating research efforts toward
clinical translation of the technology.

outlook.wustl.edu
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C a n c e rV I S I O N

Targeting cancer
TUMOR

TUMOR

Removing a tumor and minimal surrounding
tissue is rarely straightforward; typically
the exact boundaries are unclear.

Researchers have developed dye agents
that can pass through healthy cells but
remain trapped within cancer cells.

As the dye fluoresces in infrared energy,
the goggles aid in seeing the boundary
between tumor and healthy tissue.
16 Washington University School of Medicine

Technology U N V E I L E D
Achilefu dedicated five years to the project. Initially,
people were skeptical that his idea could be realized. He
carried out his research using discretionary funds from the
Mallinckrodt Institute of Radiology and support from the
Department of Defense Breast Cancer Research Program.
Achilefu assembled a multidisciplinary team, including engineers and video game specialists, who worked together to
further refine and miniaturize the glasses. Over time, Achilefu
successfully demonstrated the technology in mice, rats and
rabbits, and, in 2012, the team received a $2.8 million grant
from the National Institutes of Health (NIH).
Major collaborators include Viktor Gruev, PhD, associate professor of computer science and engineering, and Ron
Liang, PhD, associate professor of optical sciences at the
University of Arizona (UA). Washington University graduate
students Suman Mondal, Shengkui Gao and Yang Liu and
UA postdoctoral fellow Nan Zhu also played key roles.
On Feb. 10, 2014, the high-tech glasses were used during
surgery for the first time at the Alvin J. Siteman Cancer Center
at Barnes-Jewish Hospital and Washington University School
of Medicine. Surgeon Julie Margenthaler, MD, operated on
67-year-old breast cancer patient Karen Clodfelter.
In this procedure, an FDA-approved, commonly used contrast agent, indocyanine green, was injected into the patient’s
tumor. When viewed with near-infrared light, the cancerous
cells glowed blue. Lighter shades of blue indicated higher
concentrations of cancer cells.
Margenthaler was heartened by
the technology, which enabled her to
see the tumor, as well as the bordering malignant cells. (Tumors generally do not form in perfect circles,
but instead have tentacles that
branch out in different directions.)
“We’re certainly encouraged by
the potential benefits for patients,”
said Margenthaler, an associate professor of surgery at
the School of Medicine. “Imagine what it would mean if
these glasses eliminated the need for follow-up surgery
and the associated pain, inconvenience and anxiety.”
So far the technology only has been used on
patients with breast or skin cancer. Given the success
of the initial nine surgeries — four breast and five
melanoma — more are planned.
“The distinction between normal and cancerous tissue is
not always clear to the naked eye,” said melanoma surgeon
Ryan Fields, MD, a Washington University assistant professor
of surgery who also has used the goggles. “Often, we’re relying
on how something looks or feels. Even CT scans and MRI
images can fail to detect microscopic cancer.”
In a study published in the Journal of Biomedical Optics,
researchers noted that tumors as small as 1 mm in diameter
(the thickness of about 10 sheets of paper) can be detected.

Could such
technology
curtail followup surgeries?

Autumn 2014
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To care for patients, surgeons today remove the tumor
and neighboring tissue, which may or may not include
cancer cells. The samples are sent to a pathology lab and
viewed under a microscope. If the surrounding tissue
contains cancer cells, a second surgery is performed to
remove even more tissue, which also is checked for the
presence of cancer. About 20 to 25 percent of breast cancer
patients who have lumps removed require a second surgery.
It’s a balancing act — surgeons don’t want to remove too
much or too little surrounding tissue.
“No one wants unnecessary surgery — not surgeons,
not nurses and certainly not patients or their families,”
said Achilefu, also a professor of biochemistry and molecular
biophysics and biomedical engineering. “Our goal with
these glasses is to eliminate follow-up surgery by removing
all cancerous cells the first time.”

The ongoing refinement of the goggles, shown in their latest concept (left), involves cross-disciplinary
scientific collaboration. Some of the project contributors are pictured here, from left: Ron Liang, PhD,
Nan Zhu, Viktor Gruev, PhD, and Shengkui Gao. Inset, top: Samuel Achilefu, PhD, and Julie Margenthaler, MD.

Theoretically, the technology could be used to visualize
any type of cancer in the operating room.
Video components in the glasses allow surgeries to be
recorded. As only a small number of observing medical
students can fit into an operating room, the recordings could
serve as a useful teaching tool in a larger
auditorium. There also may be applications that could help guide physicians
practicing in remote areas.
Achilefu has worked with
Washington University’s Office of
Technology Management and has a
patent pending for the technology.

It appears to be the first contrast agent to mark cancer
cells universally — breast, prostate, liver, brain, colon,
leukemia and lymphoid cancers, even metastatic cells.
The cells glow under infrared light.
Achilefu is optimistic — pending FDA approval for a
pilot study — that human clinical
trials will begin soon. For now, his
research group — partnering in a
study with the University of Missouri
School of Veterinary Medicine —
will be removing cancerous tumors
in dogs, providing treatment hope for
the pets’ owners.
If approved for use in humans, this
targeted agent potentially could someday act not only as a marker, but also
as a way to deliver drugs directly to
Success of the cancer targeting agents could
cancer cells, sparing healthy tissue and
lead to further innovations. For example,
eliminating some surgeries. The agent
it might be possible to inject the targeting
also may shed light on how tumors
agent along with a cancer therapy, thereby
are responding to chemotherapy.
identifying and destroying cancer cells even
Another mission is born.
before tumor development begins.
“Our goal is to make sure no cancer
is left behind,” Achilefu said.

Future targets

Revolutionizing T R E AT M E N T
Achilefu, who also is co-leader of the
Oncologic Imaging Program at Siteman
Cancer Center, is seeking FDA approval
for a markedly improved contrast
agent, LS301, he is helping develop.
This agent, injected into the bloodstream, selectively enters cancer cells
anywhere in the body and stays there
longer, up to a week, in some cases.
outlook.wustl.edu
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The Human C

Effort to relate brain connectivity to individual capab
W H AT M A K E S U S T H I N K , FE E L A N D R E M E M B E R?
Why do people behave differently or have varied learning styles?
What makes people unique? The answers can be found in the
neural networks firing within our brains.
The Human Connectome Project (HCP) is a $30-million, five-year
effort to comprehensively map human brain circuitry — and its
variability — in 1,200 healthy adults using advanced, noninvasive
neuroimaging methods. Washington University, the University
of Minnesota and Oxford University are leading a 10-institution
consortium involving more than 100 investigators and staff.
The project is gathering and analyzing data, and making its
results freely available to the scientific community, in the hope
of sparking future discoveries — shedding light on healthy brain
function and, ultimately, informing doctors’ ability to diagnose and
treat disorders, such as ADHD, schizophrenia, Alzheimer’s, autism
and many others.

BY THE NUMBERS

$30 million
5 years
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300 twin pairs &
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It took centuries to arrive at today’s detailed views of Earth
as speculative imaginings yielded to exploration and technology.
While cartographers only had one Earth to map, HCP collaborators
are creating maps that may be useful in understanding billions
of human brains. Researchers are exploring the similarities and
differences that make us who we are, giving us all our unique mix
of personality quirks, mental traits and individual identities.
In short, the HCP is conducting the most complex and ambitious
mapping ever attempted: charting the intricacies of the living,
working human brain. Co-principal investigator David Van Essen,
PhD, appreciates the challenges as well as the limits of this
historic endeavor.
“In comparison with our historical efforts to chart the Earth’s
surface, the HCP will, in effect, take us from an 18th-century
representation of the cortical landscape to a 19th-century
representation,” Van Essen said.

BY MICHAEL C. PURDY
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THE EVOLUTION OF BRAIN MAPPING

1664
WILLIS

1909

BRODMANN

1988

TA L A I R AC H
B O O K AT L A S

2005

MRI STUDIES
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Left and right hemispheres

ROBERT BOSTON

Holding bookends that model the human brain:
Washington University HCP lead investigators
Deanna Barch, PhD, the Gregory B. Couch Professor
of Psychiatry and chair of the Department of
Psychology, and David Van Essen, PhD, the Alumni
Endowed Professor of Neurobiology. The HCP’s
co-principal investigators are Van Essen and
Kamil Ugurbil, PhD, a professor at the
University of Minnesota.

Understanding complexity Scientists admit the human brain
remains a mystery. Each human brain, weighing about 3
pounds, contains about 85 billion neurons, or nerve cells
— more than 12 times the number of people on Earth —
which transmit information across roughly 150 trillion cellto-cell connections known as synapses. In nearly all brain
disorders, there’s something wrong with these connections,
though, in most cases, scientists don’t yet know exactly
what has gone awry.
In the last two decades, an explosion of new brain imaging
methods has yielded vast amounts of information.

Why this study is so challenging
Researchers seek to interpret data with respect to the human brain’s
organizational features and structural dimensions. However, the size,
function and connectivity of the parts vary so greatly among individuals
that making comparisons and establishing averages becomes a key
challenge. Each critical area may connect with dozens of other areas
and the connection strengths differ over many orders of magnitude.

Anatomical
STRUC TURES

Distribution of
TISSUE

Distribution of
NEURONS

The outer cerebral cortex (gray), occupies about 80% of brain
volume but contains only about 20% of the brain’s 85 billion neurons.
Its convoluted surface has 150–200 critical areas of study, which
vary in size twofold or more across the normal adult population.
Some 80% of the neurons reside in the cerebellar cortex (gold).
This region of the brain also varies highly among individuals.
Subcortical structures (blue) occupy the remaining approximately
10% of brain volume but contain only about 1% of the neurons.

20 Washington University School of Medicine

Functional magnetic resonance imaging (fMRI), developed
in the 1990s, opened the door to direct observation of cognitive
activities. By detecting changes in blood oxygenation and
flow, fMRI produces activation maps showing which parts
of the brain are involved in specific mental processes. Using
fMRI, researchers are scanning participants while they
perform tasks and at rest.
Diffusion MRI gives insight into how regions of the brain
are physically wired together into networks that communicate electrical signals through the white matter.
Structural MRI scans clearly show the physical features
of the participants’ brains; these features vary greatly among
individuals.
See “Making connections” on page 21 to learn more about
how HCP data is being gathered from the human test subjects.
Wrinkles unraveled Much of the brain’s uniqueness is found
in the cerebral cortex, the wrinkled outer layer of the brain
often known as the gray matter.
“The cortex is like a sheet that is crumpled and folded up to
fit inside the skull,” Van Essen explained. “This folding pattern
varies from one person to another, and that makes it really
hard to just look at a brain and say, ‘okay, how is it organized?’”
Scientists already knew that the wrinkles, or folding
patterns, of the cerebral cortex are what they call “partially
heritable.” A glance at the brains of a pair of twins reveals
major differences, but closer study uncovers structural
elements that strongly suggest common genetic influences.
Prior to the Connectome, Van Essen was a leader in the
application of visualization techniques that effectively inflate
the crumpled sheet into a spherical beach ball, making it easier
to match up significant features from one brain to the next.
Through the advanced scanning and data-analysis techniques developed and applied by HCP, scientists have created
another tool for standardizing these comparisons: maps of
myelin, the protective white material that wraps many nerve
cell branches. Connectome scientists devised ways to use
aspects of this material like the mountains, rivers and other
landmarks that helped earthly mapmakers get their bearings.
Autumn 2014

Making connections
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C P researchers are studying twins and their nontwin siblings, a total of 1,200 subjects, to better
understand how genes affect the wiring of the brain:
What aspects of circuitry are inherited and what aspects are
shaped by experience?
To reflect the true normal range of brain connections,
study volunteers come from all racial, ethnic, economic
and educational backgrounds.
Study volunteers spend about four hours over two days
in a customized MRI, sometimes lying quietly and sometimes
performing tasks. All the while, the machine is recording
patterns of brain activity. A participant might move her right
hand, for instance, and a section of the left motor cortex
lights up. The testing is replicated in hundreds of subjects.
For something more complicated, such as a working
memory test, several brain regions in the front
and back light up together, working in a coordinated way.
“We are trying to understand which parts of brains
are active when people are processing information,
doing math or remembering things,” explained Deanna
Barch, PhD, lead investigator, who is coordinating data
collection at Washington University.
In addition to the brain scans, research volunteers undergo
a battery of cognitive, physical fitness and psychological
tests. They spend about six hours participating in wideranging activities — from tasting mysterious liquids on a
cotton swab to running around traffic cones in a corridor.
These tests, which look at intelligence, sensory abilities
and emotional state, among other aspects, bring added
dimension to the imaging data. For instance, do differences
in brain circuits have any bearing on high or low IQ?

Tucker Hartley and Owen Footer, HCP research assistants, perform
some behavioral tasks used by the HCP to measure each subject’s abilities,
such as gait speed (top), odor identification (middle), and taste (bottom).
At right, Footer prepares Hartley for a functional MRI scan in which the
subject indicates choices with a button box.
outlook.wustl.edu
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Myelin Red and yellow regions have
high myelin content compared to other colors.
Mapping the myelin on the cortex indicates
functionally distinct brain regions — an
important step toward understanding how
brain networks form dynamically to do tasks.

“We think there are about 150 to 200 cortical areas —
analogous to the political subdivisions of Earth’s surface
— that are critically important for understanding brain
function and connectivity,” Van Essen said. “Myelin maps
give us markers for an interesting subset of this mosaic of
areas. We can see these markers in individual subjects and
watch how their location jumps around from one subject
to the next.”
One of Van Essen’s MD/PhD students, Matthew Glasser,
is leading an effort to create a new master map of the cortex
based on combining myelin maps with other HCP data.
They expect to unveil the map this year.
Future implications HCP scientists made their fourth large

data release earlier this year, doubling the data they have
made available to the public.
The release included scanning, demographic and
behavioral data from more than 500 subjects. The information is organized in a web-accessible database called
ConnectomeDB. A software application, Connectome
Workbench, allows users to view and compare many types of

Story vs. math

Participants are
asked to listen attentively to either a story or
a calculation (e.g. “16 minus 5 plus 18 equals”)
and answer a question about what they
heard. Stories activate yellow and red regions,
whereas math affects green and blue regions.

imaging data, both produced by HCP and by other labs.
“These maps are going to have a major impact on our
understanding of the healthy adult human brain, and that
impact is already starting to be felt,” Van Essen, said. “Not
only have we published many papers on what we’re learning
about the brain from the data-gathering process, there also
already have been a handful of independent investigators
who have published papers based on HCP data. We weren’t
expecting that this early in the process.
“We’re approaching the point where we have enough
data to really sink our teeth into these questions and are
starting to do some serious science on what factors influence
the folding of the cortex,” he said.
Lead investigator Barch said that to comprehend how
structural or functional connectivity goes awry, researchers
must first establish the parameters of normal connectivity.
“You need a baseline to work from,” she said. “Down
the road, the HCP will become a benchmark enabling us to
see how abnormalities contribute to or result from disease.
It will suggest better ideas about disease prevention or the
means of early intervention.”

The ‘state’ of the art in brain mapping
Imagine mapping population centers

Population centers
of individual callers

22 Washington University School of Medicine

by tracking telecommunications activity —
say, grouping at least 100,000 phone calls
from one location to another. This would
reveal Kansas City and St. Louis as two hot
spots in Missouri, but would not identify
individual callers. HCP mapping, somewhat
similarly, monitors the overall activity of
more than 100,000 neurons at a time. This
allows researchers to better understand
the brain’s functional hot spots and their
connectivity, providing the most detailed and
accurate whole-brain portrait yet developed.

Regions of activity from
1,000s of neurons
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At rest Average functional connectivity
is collected on subjects while at rest in the
MRI scanner. Yellow regions are functionally
connected to a “seed” location in the right
hemisphere, whereas regions in blue and purple
are weakly connected or not connected at all.

What we can do for

CANTU
The world’s only clinic
explores the science
behind a rare syndrome
BY MICHAEL C. PURDY

At the Cantu clinic,
Cole Eggemeyer shows
he’s got what it takes.

outlook.wustl.edu
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or seven years, Randall and Rachel
Lamfers struggled to get a diagnosis for
their son, Noah, who was born prematurely, had
problems with pulmonary hypertension and needed
a breathing tube. In November 2013, analysis of
Noah’s DNA finally gave them a diagnosis: a rare
condition called Cantu syndrome.
An Internet search quickly led them to
Washington University. And this summer, the
Lamfers, who live in South Dakota,
brought Noah to St. Louis.
In June, researchers
and physicians at the
School of Medicine
and St. Louis
Children’s
Hospital hosted
the world’s only
medical clinic
for patients
with Cantu
syndrome,
providing some
treatment options
Dorothy Grange, MD,
examines Riley Dyck
and support for
during the Cantu clinic.
families, who,
until this time,
may have never met
others with the disorder.
A scientific symposium was held
in conjunction with the clinic.
Medical literature reports only about 50
people with Cantu, but many more now are being
identified by genetic analysis, and the researchers
already are following six patients in the St. Louis
area, indicating that the syndrome may be
significantly more common than first realized.
Cantu syndrome causes excessive hair growth,
bone abnormalities, swelling in the legs, problems
with heart function and a range of other symptoms
that researchers are just beginning to quantify.

24 Washington University School of Medicine

A major focus of the Cantu syndrome clinic
has been in-depth study of the cardiovascular
abnormalities associated with the condition.
This June marked the second time the clinic was
held at the St. Louis campus.
Dorothy K. Grange, MD, professor of pediatrics
in the Division of Genetics and Genomic Medicine,
created a registry for Cantu syndrome patients; in
August 2013, she organized the first clinic, along
with professor Gautam K. Singh, MD, instructor
Mark D. Levin, MD, and assistant professor Beth A.
Kozel, MD, PhD, all in the Department of Pediatrics.
“We’ve been waiting a long time for this,” Rachel
Lamfers said. “We’re excited to be able to introduce
Noah to other children with Cantu syndrome, and
we want to hear the stories of other families who
have children affected by this condition.”
At the first clinic, Tracy Buerck-Eggemeyer’s
son, Cole Eggemeyer, then 12, was fearful of
having his blood drawn.
“He asked me, ‘Mom, is having my blood drawn
going to help other people who have Cantu syndrome
in the future?’” recalled Buerck-Eggemeyer. “When
I told him yes, he said, ‘I want to do it.’”

Bench-to-bedside link
The Cantu clinic and collaborative research efforts
came about when roads coverged for two different
groups at Washington University Medical Center.
At St. Louis Children’s Hospital, Grange and
Singh, professor in the Division of Pediatric
Cardiology, were treating a family with multiple
cases of Cantu syndrome. The researchers were the
first to suggest that Cantu is
Connor Dyck
caused by a defect in a potassium channel gene that affects
the cardiovascular system.
Meanwhile, Colin Nichols,
PhD, the Carl Cori Professor
in cell biology and physiology
and director of the Center for
Investigation of Membrane
Excitability Diseases
(CIMED), had linked potassium channels — openings in
the surfaces of cells that let in
charged potassium particles
— to neonatal diabetes. To understand the role of
a related channel, he had mutated the underlying
gene in the cardiovascular system in mice.
In late 2012, the two groups realized that their
investigations were linked. The CIMED scientists
discovered their mice models with mutated
Autumn 2014
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Cantu syndrome can cause heart
chamber enlargement, low blood
pressure and fluid build-up.
Ultrasound provides a detailed view
of Noah Lamfers’ heart in motion
(inset). Gautam K. Singh, MD, discusses the care recommendations
with Noah’s mother, Rachel.

potassium channels had Cantu-like symptoms. At
about the same time, the clinicians’ genetic studies,
conducted in collaboration with a group of Dutch
researchers, led them to a gene called ABCC9.
“That’s not the same gene we were studying;
we had mutated a gene called KCNJ8 in our mice,”
Nichols said. “But we knew that proteins from each
of these two genes come together to form a single
potassium channel, and we now know that mutations in either gene can cause Cantu syndrome.”
Due to these mutations, the potassium channels
remain open, making it harder for blood vessels
to contract, a step that helps the circulatory system
increase blood pressure when needed.
CIMED, a BioMed 21 interdisciplinary research
center, specializes in studying these kinds of
changes. Problems with these channels can lead to
neurological and psychological disorders, cardiac
arrhythmias, cystic fibrosis, diabetes and myriad
other conditions. Nichols and the members of
CIMED — which now include Grange and Singh
— focus on improving therapies for these diseases.

Moving forward

normally after birth in many Cantu patients.
It may also help us find new ways to close off this
blood vessel in other situations.”
Based on what they’ve learned from studying
Cantu syndrome patients, Washington University
researchers now know more about how drugs such
as Rogaine or minoxidil stimulate hair growth.
“Because of the gene mutation they carry,
these patients are experiencing the equivalent of
a chronic overdose of minoxidil,” Nichols said.
The clinic’s discoveries may not only help
develop appropriate treatments for the cardiovascular problems and excess hair growth seen in
Cantu and in other conditions, but also aid in the
search for improved drugs that promote hair growth.
“The advances in our knowledge about Cantu
syndrome have been incredible in the last two
years,” Grange said. “I am optimistic we will have
effective therapy for our patients in the near future.”

BioMed 21
Dedicated to speeding
the transformation of
basic science discoveries
into advances in the
clinical diagnosis and
treatment of disease.
The Center for
Investigation of
Membrane Excitability
Diseases (CIMED)
cimed.wustl.edu

Hold tight! Colin Nichols, PhD, measures Riley Dyck’s ability to maintain his grip
for up to two minutes. Such measures will establish a baseline for Riley’s condition
and allow physicians to accurately gauge future changes and benefits of therapy.

Nichols said he believes the Cantu group is on
the verge of significantly alleviating the marked
lifestyle and clinical problems from which these
patients suffer, and is gearing up for trials of a
targeted drug therapy.
“Until now, Cantu syndrome patients have
been treated solely on the basis of their symptoms,
and what we’re learning now about the actual
causes of those symptoms suggests that there may
be better ways to treat them,” Nichols said.
“For example, even before the link to Cantu
syndrome was identified, we were finding evidence
that the mutation we were studying in mice causes
blood vessels to relax,” Nichols added. “That can
explain why the ductus arteriosus, a vessel that
redirects blood flow during fetal life, fails to close
outlook.wustl.edu
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Leading Together

The Campaign for Washington University

A legacy of
gratitude

B Y R I C K S K W I OT

The commitment of one family has made a profound difference.
Breakthroughs in developing leukemia therapies, in treating
osteoporosis and childhood asthma, in fighting viruses that cause
blindness, and in understanding Alzheimer’s disease — these and
countless other advances have come about with the aid of one
St. Louis couple, the late Alan A. and Edith L. Wolff. Together they
Thanks to the far-reaching
vision of the late Alan A.
and Edith L. Wolff, countless
lives are changing through
improved patient care,
breakthrough research
and student mentorship.
The couple’s estate has
endowed 20 professorships
in perpetuity at the School
of Medicine.

donated more than $70 million to the School of Medicine to fight
cancer and other diseases and to support the scientists and physicians
responsible for the medical breakthroughs.
“The power of philanthropy to change people’s lives and improve
the well-being of future generations is undeniable,” said Chancellor
Mark S. Wrighton. “Patients here at the Medical Center and around
the world have benefited from the generosity of supporters such
as Alan and Edith Wolff — through improved patient care, new
treatments and a deeper understanding of the causes of diseases.
“Through their gifts, which continue to fund the work of worldrenowned physicians and researchers, the Wolffs have left a lasting
legacy by advancing medicine and science. In the process they have
earned the gratitude of us all.”
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The Wolff legacy endures

Alan and Edith Wolff lived a quiet life, according to

those who knew them, remaining in the same
unassuming home despite their growing wealth.
But their dynamic work as civic benefactors and
philanthropic leaders over the years has helped
Washington University excel in medical science,
enabling its researchers and physicians to make
advances that benefit
patients worldwide and
continue to propel new,
life-saving discoveries.
The Wolffs found success developing subdivisions and shopping centers
in Missouri, Illinois and
Kansas. But they created a
lasting legacy through their
— Larry J. Shapiro, MD efforts to help those in
need and those striving to
advance medical care.
“The 20 endowed professorships that the Wolffs
have established in perpetuity enable us to recruit
and retain world-class talent dedicated to continuing our cutting-edge biomedical and translational
research,” said Larry J. Shapiro, MD, executive
vice chancellor for medical affairs and dean of
the School of Medicine.
After Alan Wolff’s death in 1989, Edith Wolff
From left: Wolff
took
over Wolff Construction Co. and its subsidProfessors Daniel C.
iaries,
successfully expanding its assets. She also
Brennan, MD; Chyi-Song
expanded
the family’s philanthropic efforts.
Hsieh, MD, PhD; and

“Our ongoing quest to
understand, diagnose and
treat disease depends in
large part on people like
the Wolffs.”

Daniel S. Ory, MD.

28 Washington University School of Medicine

In 2007, she made a $20-million commitment
to Washington University School of Medicine to
establish the Alan A. and Edith L. Wolff Institute,
underwriting promising biomedical research
and serving as the principal support for the
university’s BioMed 21 initiative. Other multimillion-dollar gifts went to fund cancer research
and to endow an interest-free loan fund for
medical students.
Shapiro said that informed, thoughtful and
targeted philanthropy like the Wolffs’ significantly influences medical science.
“Such philanthropic support is vital as federal
research budgets tighten, and at a time when
we are on the verge of so many new discoveries
thanks to the explosion of knowledge in
genetics and molecular biology,” Shapiro said.
“Our ongoing quest to understand, diagnose
and treat disease depends in large part on people
like the Wolffs.
“The Wolffs’ impact is immeasurable,”
Shapiro said.
But in some ways the Wolffs were unlike many

other successful people, according to their longtime attorney James L. Fogle.
“Mr. Wolff was particularly quiet about the
extent of their wealth, and they were rather quiet
about their generosity as donors when he was
alive. But then Edith increasingly took a higherprofile leadership role in order to encourage
others to give as well,” Fogle said.
“They didn’t have children. Edith focused on
helping people who couldn’t take care of themselves and to supporting people aspiring to do
great things,” he said. In addition to medical
research, many community organizations benefitted from Edith Wolff’s generosity.
She died in 2008 at age 93.
Although the Wolffs’ relationship with the
Medical Center dates back to when Edith, at age
16, volunteered at the original Jewish Hospital,
they were first inspired to support Washington
University by the late I. Jerome Flance, MD,
professor emeritus of clinical medicine.
Flance, a close friend and their personal
physician for more than 50 years, fueled their
interest in the medical research being done at
the School of Medicine and helped guide them
in their initial contributions to the university.
Autumn 2014
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Wideranging
impact

A gallery of Wolff Professors in action — clockwise from top:
Urologist Arnold D. Bullock, MD, advises a resident in the operating
room; geriatrician David B. Carr, MD, assesses driving skills in older
adults; Daniel C. Link, MD, studies the genomics of leukemia; and
Mario Castro, MD, MPH, listens to the lungs of a patient with asthma.
Outlook 29

The Wolff
professors
Wolff Professors are leaders in many disciplines
at the School of Medicine. Following is a list of
William A. Peck, MD
Alan A. and Edith L. Wolff
Distinguished Professor of Medicine

professors and dates of installation. Five more
professors will be added, bringing the total to 20.

S E P T. 9 , 2 0 0 2

Daniel C. Link, MD
Alan A. and Edith L. Wolff
Professor of Medicine

Richard K. Wilson, PhD
Alan A. and Edith L. Wolff
Distinguished Professor of Medicine

J U LY 1 , 2 0 0 9

M A R C H 2 0 , 2 014

L. David Sibley, PhD

Todd P. Margolis, MD, PhD

Alan A. and Edith L. Wolff Distinguished
Professor of Molecular Microbiology

Alan A. and Edith L. Wolff Distinguished
Professor of Ophthalmology and Visual Sciences

A U G . 1 0 , 2 0 11

A P R I L 4 , 2 014

Daniel C. Brennan, MD

Arnold D. Bullock, MD

Alan A. and Edith L. Wolff
Professor of Renal Diseases

Alan A. and Edith L. Wolff Distinguished
Professor of Urology

A U G . 8 , 2 0 13

J U N E 18 , 2 014

Chyi-Song Hsieh, MD, PhD

David B. Carr, MD

Alan A. and Edith L. Wolff
Professor of Rheumatology

Alan A. and Edith L. Wolff
Professor of Geriatric Medicine

A U G . 13 , 2 0 13

AU G . 14 , 2 014

Daniel S. Ory, MD

John Turk, MD, PhD

Alan A. and Edith L. Wolff
Professor of Cardiology

Alan A. and Edith L. Wolff
Professor of Endocrinology

A U G . 15 , 2 0 13

S E P T. 4 , 2 0 1 4

Lee Ratner, MD, PhD

Lilianna “Lila” Solnica-Krezel, PhD

Alan A. and Edith L. Wolff
Professor of Oncology

Alan A. and Edith L. Wolff Distinguished
Professor of Developmental Biology

S E P T. 2 3 , 2 0 13

N O V. 3 , 2 014

Mario Castro, MD, MPH

Aaron DiAntonio, MD, PhD

Alan A. and Edith L. Wolff Professor of
Pulmonary and Critical Care Medicine
D E C . 12 , 2 0 13
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Alan A. and Edith L. Wolff
Professor of Developmental Biology
D E C . 11 , 2 0 1 4
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In their own words
Below, in their own words, meet three Alan A. and Edith L. Wolff Distinguished
Professors. They discuss the role of philanthropy in advancing medical science and
the impact of the Wolff legacy on the School of Medicine.

A lasting impact
“Jerry Flance, a great internist and

Washington University clinical professor, introduced me to Edith, his patient and close friend
in the 1990s. I had the privilege of visiting with
Edith frequently thereafter. When her husband,
Al, passed away, Edith’s deft leadership continued
to advance his flourishing real estate business.
Al’s estate included funds to be held for the support of medical research and Edith was able to use
her own funds and estate for the same purpose.
“With the advice of Jerry Flance, Edith proceeded to provide funds for multiple outstanding
Washington University scientists. Edith had a
passion for excellence and ‘invested’ accordingly.

William A. Peck, MD
In addition to supporting the research, Edith’s funds
have established multiple endowed chairs at our
institution, enhanced by actual research support.
“Forgetting about me, excellent scientists and
department heads have been so honored, including leaders in a wide variety of missions from
geriatrics to genomics.
“Edith knew the impact that these investments
would have over the lasting lifetime of our institution: support for leadership and research, enabling
the recruitment and retention of outstanding
faculty and enhancing their productivity. This
incredibly creative philanthropy is likely to yield
an enormous positive impact worldwide.”

ROBERT BOSTON

William A. Peck, MD, director
of the Center for Public Health,
was the first Wolff Distinguished
Professor, named in 2002, when
he served as dean of the School
of Medicine and executive vice
chancellor for medical affairs.
A noted clinician and researcher
in bone and mineral metabolism,
he served as founding president
of the National Osteoporosis
Foundation.
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The Wolff legacy endures

Building excellence
“The amount of NIH [National Institutes of

Health] support has been shrinking for the past
15 years. The core modular grant of $250,000
hasn’t changed, it’s much harder to get a grant,
and the buying power has decreased dramatically.
“If a researcher doesn’t get a grant, it takes nine
months to turn around another submission —
and so who covers the research in that interim?
Even the best scientists in the world don’t always
get the grant, and even if they do, it’s not going
to cover the costs of research. So the way we need
to do this is through philanthropy.
“My attitude about philanthropy is this:
Whenever patients get a good result, they thank
the physician. But what they are really thanking

Todd P. Margolis, MD, PhD

are the physician’s skill and training and the
research that allowed him or her to use the most
modern methods — all of which need to be
supported in one way or another.
“Philanthropy in medicine is absolutely critical.
Institutions used to be able to make up the money
from clinical services, but those days are pretty
much gone. It’s very hard to do that the way insurance has gone and where health care is going.
“Endowed professorships and research funds —
such as the ones the Wolffs established — allow
us to offset some of the costs and recruit the best
people and allow us to have funding for pilot
projects and interim funding — bridge funding —
for individuals, and it gives us some flexibility.”
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Earlier this year, Todd P. Margolis,
MD, PhD, was named chair of the
Department of Ophthalmology
and Visual Sciences and
ophthalmologist-in-chief at
Barnes-Jewish Hospital. Former
president of the world’s largest
eye and vision research organization, the Association for Research
in Vision and Ophthalmology,
his own research focuses on the
herpes simplex virus and blindness. He was named a Wolff
Professor in April.
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Opening new avenues
“Philanthropic support for research is

particularly important currently for many reasons.
Number one is that we are witnessing an unprecedented potential for biomedical sciences
right now. There are many technologic breakthroughs that allow us to ask questions that we
were not able to ask before. They allow us to study
diseases and now recognize the genetic codes of
diseases that we were not able to do previously,
and not at the rate we can do now.
“From the perspective of the Department of
Developmental Biology, there are entire areas
that relate to adult stem cells and embryonic stem
cells that really open completely new avenues
to study and understand birth defects, and to
study aging and ameliorate the effects of aging.
We are living in times of absolutely remarkable
potential for biological sciences.
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Lilianna Solnica-Krezel, PhD

“We are witnessing financial limitations because
federal funding for research is going down in all
practical terms. This fiscal tightening in biomedical
research discourages many young people from
choosing science as a calling.
“Philanthropic support — such as the two
endowed professorships in our department —
becomes more crucial as the only means to
provide support for imaginative high-risk, highpotential-payoff investigations that can transform
the way we understand, diagnose and treat disease.
“Philanthropic support touches our department
and all departments of Washington University.
It is truly welcome — and we are so grateful for
our donors — because it allows us to retain the
most talented faculty and also allows these faculty
to have freedom of investigation, to ask the most
important questions and not be limited by the
current fiscal constraints.”

Lilianna Solnica-Krezel, PhD,
head of the Department of
Developmental Biology,
will be installed as a Wolff
Distinguished Professor in
November. Using advanced
imaging and genetic
techniques, she studies
embryonic development in
zebrafish models to better
understand similar processes
in human development.
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classnotes
1940 S
William Anderson, MD 42, is retired in
Williamsburg, Va., and enjoys reading and
attending movies, plays and shows.
Clayton Manry, MD 44, is retired and living
in Redwood City, Calif. His hobbies include
gardening and orchid culture.

1950 S
Irving Kushner, MD 54, is professor emeritus of medicine at Case Western Reserve
University and served as a medical expert
for the Social Security disability system. He
spends his free time writing and reading
and has published several articles recently.
Richard Aach, MD 59, and his wife are
happy to have returned to St. Louis. In
addition to attending Lifelong Learning
Institute classes through University
College, Aach enjoys photography, gardening and visiting the Saint Louis Art
Museum. He was inducted into Clayton
High School’s Alumni Hall of Fame in May.

1960 S
Gabriel Zatlin, MD 60, has retired from
patient care and teaching medical students and residents. He and his wife,
Jan, now enjoy spending time at their
Connecticut home, watching the fauna
and growing vegetables.
John Bigger, MD 64, is an active volunteer
with local arts groups in South Carolina,
including serving as president of the
North Augusta Arts Council and as treasurer of the Arts and Heritage Center. He
and his wife have 12 grandchildren.

1970 S
James Hudson, MD 75, was the 2013 recipient of Alton Memorial Hospital’s prestigious Chairman’s Award. After more than
34 years, he has retired from the practice
of ophthalmology in Alton, Ill., and now
enjoys spending time with his four young
grandsons.
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Pamela McLain, MD 77, is symposium
director for the North American Young
Rheumatology Investigator Forum. Now in
its eighth year, the forum promotes mentoring and networking with rheumatology
fellows across North America. She is proud
to note that fellows from Washington
University have attended, presented their
research and been given the best abstract
award.

1980 S
Chandlee Dickey, MD 89, is director of the
Harvard South Shore Psychiatry Residency
Training Program and assistant professor
at Harvard Medical School. Since switching
into education, she enjoys mentoring the
residents and creating innovative teaching
experiences.
Ellen Reynolds, MD 89, is medical director
of the Department of Children’s Surgery at
St. Luke’s Regional Medical Center in Boise,
Idaho. In her free time, she is a swimmer,
and holds national and world records
for her age group with U.S. Masters
Swimming.

1990 S
Melissa Piasecki, MD 91, is the senior
associate dean for academic affairs and a
professor of psychiatry at the University
of Nevada School of Medicine.
Grant Hoekzema, MD 94, was named
chair of the Council of Academic Family
Medicine for 2013-14. He recently completed a three-year term as president
of the Association of Family Medicine
Residency Directors. Hoekzema is program
director for Mercy Family Medicine in
St. Louis.

2000 S
Kenisha Campbell, MD 04, is assistant
professor of pediatrics, medical director of Adolescent Primary Care & Family
Planning Services, and co-director of
Adolescent Medicine Outpatient Rotation
at Children’s Hospital of Philadelphia.

She enjoys spending time with her son,
staying active at the gym and playing
tennis.
Elliott Weiss, MD 10, has been selected
for the Penn Fellowship in Advanced
Biomedical Ethics. He will work toward a
Master of Science in Medical Ethics at the
University of Pennsylvania while continuing his neonatology fellowship at the
Children’s Hospital of Philadelphia.

In Memory
Rebecca Kay Acquisto, OT 99
Acquisto, 55, of Longmont, Colo., died
Saturday, April 5, 2014, at the age of 55
from complications of a brain tumor. She
attended Texas Women’s University, where
she graduated with honors before receiving a master’s degree from Washington
University. In her free time, Acquisto
enjoyed beekeeping, backpacking, watercolor painting, gardening and knitting.
Through her work and her personal life,
she loved helping people, cherished her
friendships and will be dearly missed. She
mentored and supported many women
over her lifetime.
Karen Arnold, MD 68, HS 69
Arnold, 72, of Mechanicsburg, Pa., and
formerly of St. Louis and Belleville, Ill., died
Monday, April 28, 2014. After attending
the University of Notre Dame and receiving a medical degree from Washington
University, Arnold proudly served in the
U.S. Air Force as a physician. Afterward she
returned to St. Louis where she was a general and vascular surgeon before retiring
in 2002. Arnold then worked at FairCode
Associates for more than eight years until
her death. She was a faithful member of
Saint Katharine Drexel Catholic Church
where she served on the Women’s Council
and attended daily Mass.
Terrell Covington Jr., LA 40, MD 43
Covington died Sunday, April 13, 2014,
at 95. After graduating from WUSM,
he undertook a rotating internship as
a second lieutenant in the U.S. Army
Corps, eventually training as an officer
following World War II. He went to North
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Carolina to serve as a ward physician of a
1,200-bed temporary hospital overseen
by the Jefferson Medical College treating the sick and injured soldiers from the
Pacific Theatre. After nine months, he was
transferred to Fort Belvoir in Virginia and
became chief of medicine and headed
the dispensary. In 1950, Covington moved
to Tulsa where he dedicated his life to
community development and projects
related to health-care needs. He practiced
at St. John Hospital for almost 50 years
where he became chief of staff in 1971.
Covington retired at the age of 80. He was
very proud to watch his granddaughters,
Emily, LA 12, and Anna, LA 12, receive
their white coats in August 2013 as they
began as WUSM students.
Eugene Crews III, MD 70, HS 74
Crews, of Atlanta, died Sunday, Feb. 23,
2014. He earned a medical degree and
completed a psychiatric residency at
WUSM. After service in the U.S. Navy, he
was associate professor of psychiatry at
the University of Alabama in Birmingham
(UAB) and director of UAB Psychiatric
Residency Training. Crews was inducted
into the Missouri Athletic Hall of Fame
in 1962 for shot put as a University City
High School senior. He also was a Mystical
Seven scholar-athlete at the University of
Missouri-Columbia and inducted into its
Hall of Fame in 2000.
Paul Cummings, MD 93
Cummings, of Portland, Ore., died
Thursday, Feb. 13, 2014, of gastric cancer.
He attended Willamette University studying science, math and humanities before
pursuing training as a physician. After
completing a medical degree, Cummings
was awarded a fellowship at the University
of Witwatersrand in South Africa, practicing both rural and inner-city medicine.
He then completed an internal medicine
residency at the University of Washington
in Seattle. Cummings later worked for
Legacy Health and focused on effective
and best practices for patient care. He is
remembered for his love of the outdoors,
strong sense of family and one of his
favorite sayings: “solvitur ambulando”
(it is solved by walking).
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Jack F. McKemie, MD 43
McKemie died Monday, April 29, 2013,
at 95. After graduating from WUSM, he
completed an internship at Barnes-Jewish
Hospital and a residency at Children’s
Medical Center in Dallas before serving in
the U.S. Army. He was a longtime pediatrician, first serving in Corpus Christi, Texas,
and then at the Santa Rosa Hospital emergency room in San Antonio.
Charles Miller Jr., MD 52
Miller died Saturday, Oct. 19, 2013. After
graduating from Washington University,
he proudly served the Kirkwood community as a physician for 42 years.
Richard H. Morrow Jr., MD 58
Morrow of Baltimore died Saturday,
Aug. 17, 2013, at 81 from pancreatic
cancer. A professor in the Johns Hopkins
Bloomberg School of Public Health since
1991, Morrow was a pioneer in the field of
international public health. Prior to joining
Hopkins, he established public health programs in Africa, taught at Harvard School
of Public Health, and directed a tropical
disease program at the World Health
Organization in Geneva, Switzerland. He
earned a bachelor’s degree in economics from Swarthmore College, a medical
degree from WUSM and a master’s degree
in public health from Harvard University.
Morrow completed a residency at the
Strong Memorial Hospital in Rochester,
N.Y. He received the 2006 Lifetime
Achievement Award from the American
Public Health Association’s International
Health Section.
C. Barber Mueller, MD 42
Mueller died Thursday, Feb. 13, 2014,
after a brief illness. He attended Blackburn
College, graduated from the University
of Illinois and received medical education
at Washington University. He was a
decorated World War II veteran, having
served in the South Pacific. Mueller was
in the first class of Markle Scholars, a
Distinguished Fellow of the American
College of Surgeons and chairman of
surgery at the Upstate Medical Center
in Syracuse, N.Y. Additionally, he was the
founding chairman of the Department
of Surgery at McMaster Medical Centre,
and was always devoted to the cause of
medical education.

David W. Talmage, MD 44
Talmage died Thursday, March 6, 2014, at
the age of 94. Born in Korea to missionaries and spending his young life there,
Talmage came to the U.S. and graduated
from Davidson College in 1941 before
attending Washington University for
medical school. From 1945–47, he served
as a medical adviser to the Korean government for the U.S. Army. He later served
two internships, one at Georgia Baptist
Hospital and the other at Barnes Hospital
where he then completed a residency
and fellowships between 1949 and 1951.
Talmage had a distinguished career at the
University of Colorado Health Sciences
Center (UCHSC), the University of Chicago
and the University of Pittsburgh. He
served in many roles at these institutions,
including professor, department chairman, associate dean of research affairs
and dean of the faculty at UCHSC. He
was elected to the National Academy of
Sciences in 1976. Other awards include
the Bonfils-Stanton Foundation Award,
the Sandoz Prize for Immunology and two
honorary Doctor of Science degrees. He
also was a member of Phi Beta Kappa and
Alpha Omega Alpha.
Ljubinka “Louise” Vojcanin, NU 50
Vojcanin died Thursday, March 6, 2014, at
86. Born in St. Louis, she graduated from
Cleveland High School before attending the Washington University School of
Nursing. Vojcanin served as a registered
nurse at Barnes Hospital, Anheuser-Busch,
Holy Cross Hospital, Nabisco Brands
and in private practice. She was a past
president of Holy Trinity Orthodox Church
Choir, national secretary and historian of
the Federation of Serbian Sisters Circles,
and member of the Sisters Circles of
the Myrrh-bearing Women of St. Sava
Monastery, St. George (Schereville),
St. John the Baptist (Bellwood), and
Holy Trinity (St. Louis).
If you wish to make a tribute gift in honor
of any of the above alumni or faculty, please
contact: Pamela Buell, Washington University
Medical Alumni and Development, Campus Box
1247, 7425 Forsyth Blvd., Suite 2100, St. Louis MO
63105-2161, (314) 935-9691.
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advancing health

Together
transforming lives

Thank you to the many alumni and friends
who have supported Leading Together: The
Campaign for Washington University through an

Planned giving benefits include:
n

Significant charitable deductions

n

Capital gain tax benefits

changing impact of the scholarships, professorships,

n

Estate tax benefits

research and clinical care these gifts will fund.

n

Lifetime payments to you and/or loved ones

Planned gifts shape the School of Medicine, from

To learn how you can make a planned gift,
contact the Office of Planned Giving:

estate gift, life income plan or other planned gift.
Countless individuals will benefit from the life-

endowed scholarships, such as the Jackson Johnson
Scholars, to innovative research centers, including

(800) 835-3503 or (314) 935-5373

the Grace Nelson Lacey Glaucoma Research Center.

plannedgiving.wustl.edu

Together, we can change lives!
For information on supporting the School of Medicine
through an outright gift, contact:
Pamela Buell, Associate Vice Chancellor for
Medical Alumni and Development
(314) 935-9698

email: meddev@wustl.edu
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Consult with your legal or tax adviser before making a charitable gift.
Winter 2013–14

No small achievement
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Four-year-old Ian Rimer accepts a medical degree on
behalf of his dad, Ryan, from Dean Larry J. Shapiro, MD,
during the May 15 Commencement ceremony. Ryan,
who has wanted to be a physician since he was 10,
earned his long-awaited degree after previously working
as a Nevada firefighter-paramedic. He remains in St. Louis
for a diagnostic radiology residency at Barnes-Jewish
Hospital. A father of four, he is married to Jamie Rimer,
a postdoctoral researcher at the university.
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Office of Medical Public Affairs
Campus Box 8508
4444 Forest Park Ave.
St. Louis, MO 63108

NONPROFIT ORG.
U . S . P O S TA G E
PA I D
S T. LO U I S , M O
PERMIT 2535

Now
online

The Ellen S. Clark Hope Plaza re-creates a Missouri woodland, with an infinity fountain as a serene centerpiece. A new, mobilefriendly website offers a guide to the medical campus’s central green space. Discover the concept behind the plaza’s design,
locate and identify plants and explore growth details provided by the Missouri Botanical Garden: hopeplaza.wustl.edu
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